Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immucell (ICCC) Tax Provisions (2016 - 2025)

Immucell's Tax Provisions history spans 16 years, with the latest figure at $3306.0 for Q4 2025.

  • For Q4 2025, Tax Provisions fell 45.23% year-over-year to $3306.0; the TTM value through Dec 2025 reached $11570.0, up 15.06%, while the annual FY2025 figure was $11570.0, 15.06% up from the prior year.
  • Tax Provisions reached $3306.0 in Q4 2025 per ICCC's latest filing, down from $4456.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $8043.0 in Q3 2021 to a low of $229.0 in Q3 2023.
  • Average Tax Provisions over 5 years is $2393.9, with a median of $1517.5 recorded in 2022.
  • Peak YoY movement for Tax Provisions: plummeted 94.08% in 2023, then surged 485.15% in 2024.
  • A 5-year view of Tax Provisions shows it stood at $1122.0 in 2021, then surged by 34.58% to $1510.0 in 2022, then dropped by 10.73% to $1348.0 in 2023, then surged by 347.77% to $6036.0 in 2024, then plummeted by 45.23% to $3306.0 in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Tax Provisions are $3306.0 (Q4 2025), $4456.0 (Q3 2025), and $1904.0 (Q2 2025).